Psychopharmacology and Psychiatry Updates

Un pódcast de Psychopharmacology Institute

Categorías:

213 Episodo

  1. Medications for Binge Eating Disorder

    Publicado: 17/4/2022
  2. Antipsychotics for First Episodes of Psychosis

    Publicado: 12/4/2022
  3. Effects on Suicidal Risk With Different Medications

    Publicado: 7/4/2022
  4. Risks of Using Cannabinoids

    Publicado: 2/4/2022
  5. Lithium: How to Manage Dosage

    Publicado: 28/3/2022
  6. CBD as a Medication

    Publicado: 23/3/2022
  7. SSRIs and Suicidality

    Publicado: 18/3/2022
  8. Cannabis and Cognition

    Publicado: 13/3/2022
  9. Clozapine-Induced Myocarditis

    Publicado: 8/3/2022
  10. Does Cannabis Use Cause Psychiatric Disorders?

    Publicado: 3/3/2022
  11. Treatment Strategies for Treatment-Resistant OCD

    Publicado: 26/2/2022
  12. Lithium Augmentation for Psychotic Depression

    Publicado: 21/2/2022
  13. Prevention and Treatment Strategies for Agitation and Dementia

    Publicado: 16/2/2022
  14. Choosing an Antipsychotic for Psychotic Depression

    Publicado: 11/2/2022
  15. Neurological and Psychiatric Sequelae Due to COVID-19

    Publicado: 6/2/2022
  16. SNRIs + Antipsychotics for Psychotic Depression

    Publicado: 1/2/2022
  17. Approaches for Addressing Tobacco Use Disorder

    Publicado: 27/1/2022
  18. ECT the First-Choice Treatment for Psychotic Depression

    Publicado: 22/1/2022
  19. Metabolic Characteristics of Newer Second-Generation Antipsychotics

    Publicado: 17/1/2022
  20. Prescribing Antipsychotics During Breastfeeding

    Publicado: 12/1/2022

9 / 11

Practical psychopharmacology updates for mental health clinicians. Useful for psychiatry / mental health professionals. Expert interviews and soundbites from CME presentations. Practical and free of commercial bias. Not sponsored by any pharmaceutical company.

Visit the podcast's native language site